Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Shares Issued: 2020-2024

Historic Shares Issued for Cullinan Therapeutics (CGEM) over the last 5 years, with Dec 2024 value amounting to $262.7 million.

  • Cullinan Therapeutics' Shares Issued rose 8933.10% to $38.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was $39.5 million, marking a year-over-year decrease of 85.31%. This contributed to the annual value of $262.7 million for FY2024, which is 584.20% up from last year.
  • Latest data reveals that Cullinan Therapeutics reported Shares Issued of $262.7 million as of FY2024, which was up 584.20% from $38.4 million recorded in FY2023.
  • In the past 5 years, Cullinan Therapeutics' Shares Issued ranged from a high of $267.3 million in FY2021 and a low of $1.2 million during FY2022.
  • In the last 3 years, Cullinan Therapeutics' Shares Issued had a median value of $38.4 million in 2023 and averaged $100.7 million.
  • Its Shares Issued has fluctuated over the past 5 years, first plummeted by 99.57% in 2022, then skyrocketed by 3,229.40% in 2023.
  • Yearly analysis of 5 years shows Cullinan Therapeutics' Shares Issued stood at $145.4 million in 2020, then surged by 83.75% to $267.3 million in 2021, then crashed by 99.57% to $1.2 million in 2022, then spiked by 3,229.40% to $38.4 million in 2023, then surged by 584.20% to $262.7 million in 2024.